Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 405

1.

Long-Term Risk of Heart Failure in Breast Cancer Patients After Adjuvant Chemotherapy With or Without Trastuzumab.

Banke A, Fosbøl EL, Ewertz M, Videbæk L, Dahl JS, Poulsen MK, Cold S, Jensen MB, Gislason GH, Schou M, Møller JE.

JACC Heart Fail. 2019 Mar;7(3):217-224. doi: 10.1016/j.jchf.2018.09.001.

PMID:
30819377
2.

Synthesis and evaluation of two new candidate high-affinity full agonist PET radioligands for imaging 5-HT1B receptors.

Lindberg A, Lu S, Nag S, Schou M, Liow JS, Zoghbi SS, Frankland MP, Gladding RL, Morse CL, Takano A, Amini N, Elmore CS, Lee YS, Innis RB, Halldin C, Pike VW.

Nucl Med Biol. 2019 Jan 26;70:1-13. doi: 10.1016/j.nucmedbio.2019.01.005. [Epub ahead of print]

PMID:
30811975
3.

Relation between invasive hemodynamics and measured glomerular filtration rate by 51Cr-EDTA clearance in advanced heart failure.

Deis T, Balling L, Boesgaard S, Rossing K, Schou M, Oturai P, Wolsk E, Gustafsson F.

Scand J Clin Lab Invest. 2019 Feb 20:1-8. doi: 10.1080/00365513.2019.1576221. [Epub ahead of print]

PMID:
30784338
4.

Incidence of atrial fibrillation in conjunction with breast cancer.

D'Souza M, Smedegaard L, Madelaire C, Nielsen D, Torp-Pedersen C, Gislason G, Schou M, Fosbøl E.

Heart Rhythm. 2019 Mar;16(3):343-348. doi: 10.1016/j.hrthm.2018.10.017. Epub 2019 Jan 29.

PMID:
30709772
5.

Pulmonary PET imaging confirms preferential lung target occupancy of an inhaled bronchodilator.

Schou M, Ewing P, Cselenyi Z, Fridén M, Takano A, Halldin C, Farde L.

EJNMMI Res. 2019 Jan 29;9(1):9. doi: 10.1186/s13550-019-0479-8.

PMID:
30694407
6.

The development of a GPR44 targeting radioligand [11C]AZ12204657 for in vivo assessment of beta cell mass.

Jahan M, Johnström P, Selvaraju RK, Svedberg M, Winzell MS, Bernström J, Kingston L, Schou M, Jia Z, Skrtic S, Johansson L, Korsgren O, Farde L, Halldin C, Eriksson O.

EJNMMI Res. 2018 Dec 27;8(1):113. doi: 10.1186/s13550-018-0465-6.

7.

Epitope specificity of anti-synapsin autoantibodies: Differential targeting of synapsin I domains.

Mertens R, Melchert S, Gitler D, Schou MB, Saether SG, Vaaler A, Piepgras J, Kochova E, Benfenati F, Ahnert-Hilger G, Ruprecht K, Höltje M.

PLoS One. 2018 Dec 13;13(12):e0208636. doi: 10.1371/journal.pone.0208636. eCollection 2018.

8.

Clinical outcome in patients with implantable cardioverter-defibrillator and cancer: a nationwide study.

Christensen AM, Bjerre J, Schou M, Jons C, Vinther M, Gislason GH, Johansen JB, Nielsen JC, Petersen HH, Riahi S, Ruwald AC.

Europace. 2019 Mar 1;21(3):465-474. doi: 10.1093/europace/euy268.

PMID:
30535192
9.

Low N-terminal pro-brain natriuretic peptide levels are associated with non-alcoholic fatty liver disease in patients with type 2 diabetes.

Johansen ML, Schou M, Rasmussen J, Rossignol P, Holm MR, Chabanova E, Dela F, Faber J, Kistorp C.

Diabetes Metab. 2018 Nov 22. pii: S1262-3636(18)30218-0. doi: 10.1016/j.diabet.2018.11.003. [Epub ahead of print]

PMID:
30472196
10.

Driving following defibrillator implantation: development and pilot results from a nationwide questionnaire.

Bjerre J, Rosenkranz SH, Christensen AM, Schou M, Jøns C, Gislason G, Ruwald AC.

BMC Cardiovasc Disord. 2018 Nov 20;18(1):212. doi: 10.1186/s12872-018-0949-3.

11.

Safety and Tolerability of the Chymase Inhibitor Fulacimstat in Patients With Left Ventricular Dysfunction After Myocardial Infarction-Results of the CHIARA MIA 1 Trial.

Düngen HD, Kober L, Nodari S, Schou M, Otto C, Becka M, Kanefendt F, Winkelmann BR, Gislason G, Richard F, Nielsen OW, Gheorghiade M, Senni M.

Clin Pharmacol Drug Dev. 2018 Nov 19. doi: 10.1002/cpdd.633. [Epub ahead of print]

PMID:
30452784
12.

Prevalence of heart failure and the diagnostic value of MR-proANP in outpatients with type 2 diabetes.

Jensen J, Schou M, Kistorp C, Faber J, Hansen TW, Jensen MT, Andersen HU, Rossing P, Vilsbøll T, Jørgensen PG.

Diabetes Obes Metab. 2019 Mar;21(3):736-740. doi: 10.1111/dom.13583. Epub 2018 Dec 5.

PMID:
30447033
13.

The significance of anti-neuronal antibodies for acute psychiatric disorders: a retrospective case-controlled study.

Schou MB, Sæther SG, Drange OK, Krane-Gartiser K, Reitan SK, Vaaler AE, Kondziella D.

BMC Neurosci. 2018 Nov 3;19(1):68. doi: 10.1186/s12868-018-0471-7.

14.

Genomic signatures of experimental adaptive radiation in Drosophila.

Michalak P, Kang L, Schou MF, Garner HR, Loeschcke V.

Mol Ecol. 2019 Feb;28(3):600-614. doi: 10.1111/mec.14917. Epub 2018 Dec 4.

PMID:
30375065
15.

Incidence of new onset cancer in patients with a myocardial infarction - a nationwide cohort study.

Malmborg M, Christiansen CB, Schmiegelow MD, Torp-Pedersen C, Gislason G, Schou M.

BMC Cardiovasc Disord. 2018 Oct 22;18(1):198. doi: 10.1186/s12872-018-0932-z.

16.

A simple clinical assessment is superior to systematic triage in prediction of mortality in the emergency department.

Iversen AKS, Kristensen M, Østervig RM, Køber L, Sölétormos G, Lundager Forberg J, Eugen-Olsen J, Rasmussen LS, Schou M, Iversen KK.

Emerg Med J. 2019 Feb;36(2):66-71. doi: 10.1136/emermed-2016-206382. Epub 2018 Oct 16.

PMID:
30327415
17.

The Effect of Increasing Dialysate Magnesium on Serum Calcification Propensity in Subjects with End Stage Kidney Disease: A Randomized, Controlled Clinical Trial.

Bressendorff I, Hansen D, Schou M, Pasch A, Brandi L.

Clin J Am Soc Nephrol. 2018 Sep 7;13(9):1373-1380. doi: 10.2215/CJN.13921217. Epub 2018 Aug 21.

PMID:
30131425
18.

B-type natriuretic peptide-guided therapy for heart failure (HF): a systematic review and meta-analysis of individual participant data (IPD) and aggregate data.

Pufulete M, Maishman R, Dabner L, Higgins JPT, Rogers CA, Dayer M, MacLeod J, Purdy S, Hollingworth W, Schou M, Anguita-Sanchez M, Karlström P, Shochat MK, McDonagh T, Nightingale AK, Reeves BC.

Syst Rev. 2018 Jul 31;7(1):112. doi: 10.1186/s13643-018-0776-8.

19.

Cardiac systolic dysfunction in past illicit users of anabolic androgenic steroids.

Rasmussen JJ, Schou M, Madsen PL, Selmer C, Johansen ML, Ulriksen PS, Dreyer T, Kümler T, Plesner LL, Faber J, Gustafsson F, Kistorp C.

Am Heart J. 2018 Sep;203:49-56. doi: 10.1016/j.ahj.2018.06.010. Epub 2018 Jun 27.

PMID:
30015068
20.

Sleep Apnea, the Risk of Developing Heart Failure, and Potential Benefits of Continuous Positive Airway Pressure (CPAP) Therapy.

Holt A, Bjerre J, Zareini B, Koch H, Tønnesen P, Gislason GH, Nielsen OW, Schou M, Lamberts M.

J Am Heart Assoc. 2018 Jun 22;7(13). pii: e008684. doi: 10.1161/JAHA.118.008684.

21.

Increased Brain Exposure of an Alpha-Synuclein Fibrillization Modulator by Utilization of an Activated Ester Prodrug Strategy.

Cairns AG, Vazquez-Romero A, Mahdi Moein M, Ådén J, Elmore CS, Takano A, Arakawa R, Varrone A, Almqvist F, Schou M.

ACS Chem Neurosci. 2018 Nov 21;9(11):2542-2547. doi: 10.1021/acschemneuro.8b00236. Epub 2018 Jun 19.

PMID:
29901990
22.

Late-Stage Isotopic Carbon Labeling of Pharmaceutically Relevant Cyclic Ureas Directly from CO2.

Del Vecchio A, Caillé F, Chevalier A, Loreau O, Horkka K, Halldin C, Schou M, Camus N, Kessler P, Kuhnast B, Taran F, Audisio D.

Angew Chem Int Ed Engl. 2018 Jul 26;57(31):9744-9748. doi: 10.1002/anie.201804838. Epub 2018 Jul 3.

23.

Reply: Aspirin and Prognosis in Heart Failure: A Question of Power.

Madelaire C, Gislason G, Torp-Pedersen C, Schou M.

JACC Heart Fail. 2018 Jun;6(6):540. doi: 10.1016/j.jchf.2018.03.009. No abstract available.

PMID:
29852937
24.

Genome-wide regulatory deterioration impedes adaptive responses to stress in inbred populations of Drosophila melanogaster.

Schou MF, Bechsgaard J, Muñoz J, Kristensen TN.

Evolution. 2018 May 8. doi: 10.1111/evo.13497. [Epub ahead of print]

PMID:
29738620
25.

Linking developmental diet to adult foraging choice in Drosophila melanogaster.

Davies LR, Schou MF, Kristensen TN, Loeschcke V.

J Exp Biol. 2018 May 11;221(Pt 9). pii: jeb175554. doi: 10.1242/jeb.175554.

26.

[18F]fluoro-benziodoxole: a no-carrier-added electrophilic fluorinating reagent. Rapid, simple radiosynthesis, purification and application for fluorine-18 labelling.

Cortés González MA, Nordeman P, Bermejo Gómez A, Meyer DN, Antoni G, Schou M, Szabó KJ.

Chem Commun (Camb). 2018 Apr 24;54(34):4286-4289. doi: 10.1039/c8cc00526e.

PMID:
29632936
27.

Procoagulant State in Current and Former Anabolic Androgenic Steroid Abusers.

Chang S, Rasmussen JJ, Frandsen MN, Schou M, Johansen ML, Faber J, Münster AB, Sidelmann JJ, Kistorp C.

Thromb Haemost. 2018 Apr;118(4):647-653. doi: 10.1055/s-0038-1636540. Epub 2018 Apr 4.

PMID:
29618151
28.

Long-term effect of epirubicin on incidence of heart failure in women with breast cancer: insight from a randomized clinical trial.

Banke A, Fosbøl EL, Møller JE, Gislason GH, Andersen M, Bernsdorf M, Jensen MB, Schou M, Ejlertsen B.

Eur J Heart Fail. 2018 Oct;20(10):1447-1453. doi: 10.1002/ejhf.1168. Epub 2018 Mar 1.

PMID:
29493047
29.

CHA2DS2-VASc score and risk of thromboembolism and bleeding in patients with atrial fibrillation and recent cancer.

D'Souza M, Carlson N, Fosbøl E, Lamberts M, Smedegaard L, Nielsen D, Torp-Pedersen C, Gislason G, Schou M.

Eur J Prev Cardiol. 2018 Apr;25(6):651-658. doi: 10.1177/2047487318759858. Epub 2018 Feb 27.

PMID:
29482441
30.

[Management of cardiovascular complications secondary to medical treatment of cancer].

Banke A, Polk A, Nielsen D, Videbæk L, Overgaard U, Fosbøl EL, Vaage-Nielsen M, Nielsen KM, Schou M.

Ugeskr Laeger. 2018 Feb 12;180(7). pii: V04170269. Review. Danish.

PMID:
29465031
31.

Low-Dose Aspirin in Heart Failure Not Complicated by Atrial Fibrillation: A Nationwide Propensity-Matched Study.

Madelaire C, Gislason G, Kristensen SL, Fosbøl EL, Bjerre J, D'Souza M, Gustafsson F, Kober L, Torp-Pedersen C, Schou M.

JACC Heart Fail. 2018 Feb;6(2):156-167. doi: 10.1016/j.jchf.2017.09.021.

32.

Development of [ Carbonyl-11C]AZ13198083, a Novel Histamine Type-3 Receptor Radioligand with Favorable Kinetics.

Dahl K, Nakao R, Amini N, Moein MM, Finnema S, Malmquist J, Varnäs K, Schou M.

ACS Chem Neurosci. 2018 May 16;9(5):906-911. doi: 10.1021/acschemneuro.7b00493. Epub 2018 Jan 30.

PMID:
29359917
33.

YKL-40 in patients with end-stage renal disease receiving haemodialysis.

Nielsen TL, Plesner LL, Warming PE, Pallisgaard JL, Dalsgaard M, Schou M, Høst U, Rydahl C, Brandi L, Køber L, Johansen JS, Kastrup J, Iversen KK.

Biomarkers. 2018 May - Jun;23(4):357-363. doi: 10.1080/1354750X.2018.1428359. Epub 2018 Mar 8.

PMID:
29357700
34.

Prevalence of cardiovascular disease and evaluation of standard of care in type 2 diabetes: a nationwide study in primary care.

Rungby J, Schou M, Warrer P, Ytte L, Andersen GS.

Cardiovasc Endocrinol. 2017 Dec;6(4):145-151. doi: 10.1097/XCE.0000000000000135. Epub 2017 Oct 31.

35.

Evidence-Based Therapy and Its Association With Workforce Detachment After First Hospitalization for Heart Failure.

Rørth R, Fosbøl EL, Mogensen UM, Kragholm K, Jhund PS, Petrie MC, Schou M, Gislason GH, McMurray JJV, Torp-Pedersen C, Køber L, Kristensen SL.

JACC Heart Fail. 2018 Jan;6(1):41-48. doi: 10.1016/j.jchf.2017.09.019. Epub 2017 Dec 6.

36.

Routine blood tests are associated with short term mortality and can improve emergency department triage: a cohort study of >12,000 patients.

Kristensen M, Iversen AKS, Gerds TA, Østervig R, Linnet JD, Barfod C, Lange KHW, Sölétormos G, Forberg JL, Eugen-Olsen J, Rasmussen LS, Schou M, Køber L, Iversen K.

Scand J Trauma Resusc Emerg Med. 2017 Nov 28;25(1):115. doi: 10.1186/s13049-017-0458-x.

37.

Influence of renal impairment on aldosterone status, calcium metabolism, and vasopressin activity in outpatients with systolic heart failure.

Bosselmann H, Tonder N, Sölétormos G, Gaborit F, Rossing K, Iversen K, Goetze JP, Gustafsson F, Schou M.

ESC Heart Fail. 2017 Nov;4(4):554-562. doi: 10.1002/ehf2.12186. Epub 2017 Jul 11.

38.

Oral Magnesium Supplementation in Chronic Kidney Disease Stages 3 and 4: Efficacy, Safety, and Effect on Serum Calcification Propensity-A Prospective Randomized Double-Blinded Placebo-Controlled Clinical Trial.

Bressendorff I, Hansen D, Schou M, Silver B, Pasch A, Bouchelouche P, Pedersen L, Rasmussen LM, Brandi L.

Kidney Int Rep. 2016 Dec 30;2(3):380-389. doi: 10.1016/j.ekir.2016.12.008. eCollection 2017 May.

39.

Discovery of a Novel Muscarinic Receptor PET Radioligand with Rapid Kinetics in the Monkey Brain.

Malmquist J, Varnäs K, Svedberg M, Vallée F, Albert JS, Finnema SJ, Schou M.

ACS Chem Neurosci. 2018 Feb 21;9(2):224-229. doi: 10.1021/acschemneuro.7b00340. Epub 2017 Nov 13.

PMID:
29072902
40.

Rationale and Design of the First Double-Blind, Placebo-Controlled Trial with Allogeneic Adipose Tissue-Derived Stromal Cell Therapy in Patients with Ischemic Heart Failure: A Phase II Danish Multicentre Study.

Kastrup J, Schou M, Gustafsson I, Nielsen OW, Møgelvang R, Kofoed KF, Kragelund C, Hove JD, Fabricius-Bjerre A, Heitman M, Haack-Sørensen M, Lund LD, Johansen EM, Qayyum AA, Mathiasen AB, Ekblond A.

Stem Cells Int. 2017;2017:8506370. doi: 10.1155/2017/8506370. Epub 2017 Sep 19.

41.

[11C]AZ10419096 - a full antagonist PET radioligand for imaging brain 5-HT1B receptors.

Lindberg A, Nag S, Schou M, Takano A, Matsumoto J, Amini N, Elmore CS, Farde L, Pike VW, Halldin C.

Nucl Med Biol. 2017 Nov;54:34-40. doi: 10.1016/j.nucmedbio.2017.07.007. Epub 2017 Jul 21.

PMID:
28950161
42.

NMDA receptor antibodies are found in a small subgroup of patients with first-episode psychosis, but their clinical relevance is unknown.

Schou M, Saether SG.

Evid Based Ment Health. 2018 Feb;21(1):e1-e2. doi: 10.1136/eb-2017-102720. Epub 2017 Sep 25. No abstract available.

PMID:
28947675
43.

The prognostic significance of lung function in stable heart failure outpatients.

Plesner LL, Dalsgaard M, Schou M, Køber L, Vestbo J, Kjøller E, Iversen K.

Clin Cardiol. 2017 Nov;40(11):1145-1151. doi: 10.1002/clc.22802. Epub 2017 Sep 13.

44.

Reduction of [11 C]CO2 to [11 C]CO using solid supported zinc.

Dahl K, Ulin J, Schou M, Halldin C.

J Labelled Comp Radiopharm. 2017 Nov;60(13):624-628. doi: 10.1002/jlcr.3561. Epub 2017 Oct 19.

PMID:
28868618
45.

Increased blood pressure and aortic stiffness among abusers of anabolic androgenic steroids: potential effect of suppressed natriuretic peptides in plasma?

Rasmussen JJ, Schou M, Madsen PL, Selmer C, Johansen ML, Hovind P, Ulriksen PS, Faber J, Gustafsson F, Kistorp C.

J Hypertens. 2018 Feb;36(2):277-285. doi: 10.1097/HJH.0000000000001546.

PMID:
28863033
46.

Unexpected high genetic diversity in small populations suggests maintenance by associative overdominance.

Schou MF, Loeschcke V, Bechsgaard J, Schlötterer C, Kristensen TN.

Mol Ecol. 2017 Dec;26(23):6510-6523. doi: 10.1111/mec.14262. Epub 2017 Sep 5.

PMID:
28746770
47.

Synapsin-antibodies in psychiatric and neurological disorders: Prevalence and clinical findings.

Höltje M, Mertens R, Schou MB, Saether SG, Kochova E, Jarius S, Prüss H, Komorowski L, Probst C, Paul F, Bellmann-Strobl J, Gitler D, Benfenati F, Piepgras J, Ahnert-Hilger G, Ruprecht K.

Brain Behav Immun. 2017 Nov;66:125-134. doi: 10.1016/j.bbi.2017.07.011. Epub 2017 Jul 18.

PMID:
28733081
48.

The effect of magnesium supplementation on vascular calcification in chronic kidney disease-a randomised clinical trial (MAGiCAL-CKD): essential study design and rationale.

Bressendorff I, Hansen D, Schou M, Kragelund C, Brandi L.

BMJ Open. 2017 Jun 23;7(6):e016795. doi: 10.1136/bmjopen-2017-016795.

49.

New methodologies for the preparation of carbon-11 labeled radiopharmaceuticals.

Dahl K, Halldin C, Schou M.

Clin Transl Imaging. 2017;5(3):275-289. doi: 10.1007/s40336-017-0223-1. Epub 2017 Feb 25. Review.

50.

Evolution of sociality in spiders leads to depleted genomic diversity at both population and species levels.

Settepani V, Schou MF, Greve M, Grinsted L, Bechsgaard J, Bilde T.

Mol Ecol. 2017 Aug;26(16):4197-4210. doi: 10.1111/mec.14196. Epub 2017 Jun 27.

PMID:
28570031

Supplemental Content

Support Center